Ethyl 2-[9-(5-bromo-2-hydroxyphenyl)-3, 3,6,6-tetramethyl-1,8-dioxo-1,2,3,4,5,6,7,8,9,10-decahydroacridin-10-yl In the title compound, C 27 H 32 BrNO 5 , the central 1,4-dihydropyridine ring adopts a shallow sofa conformation (with the C atom bearing the bromophenol ring as the flap), whereas the pendant cyclohexene rings both have twisted-boat conformations. The molecule features an intramolecular O-HÁ Á ÁO hydrogen bond, which closes an S(8) ring. In the crystal, molecules are linked by C-HÁ Á ÁO interactions, forming C(12) chains along the c-axis direction. The ethyl acetate grouping is disordered over two sets of sites in a 0.719 (11):0.281 (11) ratio.
Structure description
Acridine derivatives have been used as anti-malarial (Santelli-Rouvier et al., 2004) antibacterial (Wainwright, 2001) , anti-leishmanial (Delmas et al., 2004) and anti-HIV (Hamy et al., 1998) agents. They also have exhibited excellent results in chemotherapy of cancer (Cholody et al., 1996; Rewcastle et al., 1986) . As part of our studies in this area, we report herein the synthesis and crystal structure of the title compound (Fig. 1) .
The central 1,4-dihydropyridine ring (N1/C7/C8/C13/C16/C17) of the 1, 2, 3, 4, 5, 6, 7, 8, 9 ,10-decahydroacridine ring system (N1/C7-C13/C16-C21) adopts a shallow sofa conformation [the puckering parameters are Q T = 0.229 (3) Å , = 66. 4 (8) , ' = 191.6 (8) ], while the cyclohexene rings (C8-C13 and C16-C21) of the 1,2,3,4,5,6,7,8,9,10-decahydroacridine ring system have a twisted-boat conformation [the puckering parameters are Q T = 0.472 (4) Å , = 123.9 (4)
, ' = 341.3 (5) and Q T = data reports 0.501 (4) Å , = 119.7 (5) , ' = 46.4 (5)
, respectively]. The bond lengths and bond angles in the title compound are normal and comparable to those observed in similar structures (Akkurt et al., 2015) .
In the crystal, adjacent molecules are connected by C-HÁ Á ÁO interactions, forming C(12) chains along the c-axis direction (Table 1, Fig. 2 ).
Synthesis and crystallization
A mixture of dimedone (1.12 g, 0.008 mol), 5-bromo-2-hydroxybenzaldhyde (0.81 g; 0.004 mol), ethyl glycinate hydrochloride (0.56 g; 0.004 mol) and triethylamine (1.12 ml; 0.008 mol) in 30 ml ethanol was refluxed for 5 h. The solid product was deposited on cooling and collected by filtration under vacuum. Recrystallization of the crude product from ethanol afforded light-yellow prisms in 58% yield (m.p.
K).

Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 . The title molecule exhibits disorder of the ethyl acetate group. The atoms of the ethyl acetate group were fixed with restraints (EADP and SADI commands) and had to be split over two positions. The occupancies refined to 0.719 (11):0.281 (11). Table 1 Hydrogen-bond geometry (Å ,  ) . 
Figure 2
A view along the a axis of the hydrogen bonding and crystal packing of the title compound. The minor component of the disorder is not shown for clarity. Figure 1
View of the title compound, with displacement ellipsoids for non-H atoms drawn at the 20% probability level. The minor component is not shown for clarity.
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IUCrData ( Special details Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. 
